Jörn Drappa

Technik-/Wissenschafts-/F&E-Leiter bei ALUMIS INC.

Vermögen: 1 Mio $ am 31.05.2026

62 Jahre

Health Technology

Consumer Services

Profil

Jörn Drappa was the founder of Viela Bio, Inc., founded in 2018, where the title held was Chief Medical Officer, Head-Research & Development from 2018 to 2021.
The current job is Chief Medical Officer at Alumis, Inc. starting in 2022.
Former jobs include Associate Director-Medical at Amgen, Inc. from 2003 to 2006; Senior Medical Director at Genentech, Inc. from 2008 to 2011; Vice President-Clinical Development at MedImmune LLC from 2011 to 2018; Executive Vice President-Research & Development at Horizon Therapeutics Ltd. (Ireland) in 2021; Chief Medical Officer at Ventyx Biosciences, Inc. from 2021 to 2022; and Director at Alpine Immune Sciences, Inc. from 2022 to 2024.
Education includes a doctorate from Universität zu Köln conferred in 1991 and a doctorate from Weill Cornell Medicine.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
ALUMIS INC. 0,05 %	22.05.2026	59.339 ( 0,05 % )	1 Mio $	31.05.2026

Aktive Positionen von Jörn Drappa

Unternehmen	Position	Beginn
ALUMIS INC.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2022

Alle aktiven Positionen von Jörn Drappa

Ehemalige bekannte Positionen von Jörn Drappa

Unternehmen	Position	Ende
ALPINE IMMUNE SCIENCES, INC.	Direktor/Vorstandsmitglied	20.05.2024
VENTYX BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	05.05.2022
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Technik-/Wissenschafts-/F&E-Leiter	01.09.2021
VIELA BIO, INC.	Gründer	15.03.2021
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Technik-/Wissenschafts-/F&E-Leiter	01.02.2018

Sehen Sie sich die Erfahrung von Jörn Drappa im Detail an

Ausbildung von Jörn Drappa

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jörn Drappa im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	10
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Horizon Therapeutics Ltd. (Ireland) Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases	Health Technology
Universität zu Köln Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases	Health Technology
Viela Bio, Inc. Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases	Health Technology
Weill Cornell Medicine Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ventyx Biosciences, Inc. Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases	Health Technology
Alumis, Inc. Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders	Health Technology